Family Lore, a Variant of Uncertain Significance, and CADASIL

Rhys Duarte,Liesbeth Vossaert,Sandra A. Darilek,Chelsi Rose,Evan Schauer,Christian Parobek,Emily Bland,Keren Machol,Elizabeth Mizerik,Chaya N. Murali

DOI: https://doi.org/10.1002/ajmg.c.32117

2024-10-22

American Journal of Medical Genetics Part C Seminars in Medical Genetics

Abstract:American Journal of Medical Genetics Part C: Seminars in Medical Genetics, EarlyView.

genetics & heredity

What problem does this paper attempt to address?

Novel KRIT1/CCM1 and MGC4607/CCM2 Gene Variants in Chinese Families with Cerebral Cavernous Malformations

Kang Wang,Dengchang Wu,Baorong Zhang,Guohua Zhao

DOI: https://doi.org/10.3389/fneur.2018.01128

IF: 3.4

2018-01-01

Frontiers in Neurology

Abstract:Familial cerebral cavernous malformations (CCMs) are autosomal dominant disorders characterized by hemorrhagic strokes, recurrent headache, epilepsy, and focal neurological deficits. Genetic variants in KRIT1/CCM1, MGC4607/CCM2, and PDCD10/CCM3 genes contribute to CCMs. The clinical information of two Chinese families with CCMs was collected. MRI and video-electroencephalography were performed. Genetic variants of CCM1, CCM2, and CCM3 genes were investigated by exome sequencing. The patients were presented with recurrent epilepsy or headache. Susceptibility-weighted images of brains showed many dark dots, while video-electroencephalography revealed many spikes from multiple brain regions of patients. Exome sequencing revealed a novel CCM1 genetic variant (c.1599_1601TGAdel, p.Asp533del) and a novel CCM2 genetic variant (c.773delA, p.K258fsX34) in Family one and Family two, respectively; cosegregation existed in these two families. The two family members presented typical CCMs symptoms. These two novel genetic variants in CCM1 and CCM2 genes were the causation of CCM in the two Chinese families, and our data enriched the genetic variant spectrum of CCM genes.
De novo variants implicate chromatin modification, transcriptional regulation, and retinoic acid signaling in syndromic craniosynostosis

Andrew T Timberlake,Stephen McGee,Garrett Allington,Emre Kiziltug,Erin M Wolfe,Amy L Stiegler,Titus J Boggon,May Sanyoura,Michelle Morrow,Tara L Wenger,Erica M Fernandes,Oana Caluseriu,John A Persing,Sheng Chih Jin,Richard P Lifton,Kristopher T Kahle,Paul Kruszka

DOI: https://doi.org/10.1016/j.ajhg.2023.03.017

2023-05-04

Abstract:Craniosynostosis (CS) is the most common congenital cranial anomaly. Several Mendelian forms of syndromic CS are well described, but a genetic etiology remains elusive in a substantial fraction of probands. Analysis of exome sequence data from 526 proband-parent trios with syndromic CS identified a marked excess (observed 98, expected 33, p = 4.83 × 10-20) of damaging de novo variants (DNVs) in genes highly intolerant to loss-of-function variation (probability of LoF intolerance > 0.9). 30 probands harbored damaging DNVs in 21 genes that were not previously implicated in CS but are involved in chromatin modification and remodeling (4.7-fold enrichment, p = 1.1 × 10-11). 17 genes had multiple damaging DNVs, and 13 genes (CDK13, NFIX, ADNP, KMT5B, SON, ARID1B, CASK, CHD7, MED13L, PSMD12, POLR2A, CHD3, and SETBP1) surpassed thresholds for genome-wide significance. A recurrent gain-of-function DNV in the retinoic acid receptor alpha (RARA; c.865G>A [p.Gly289Arg]) was identified in two probands with similar CS phenotypes. CS risk genes overlap with those identified for autism and other neurodevelopmental disorders, are highly expressed in cranial neural crest cells, and converge in networks that regulate chromatin modification, gene transcription, and osteoblast differentiation. Our results identify several CS loci and have major implications for genetic testing and counseling.
Regulatory elements in SEM1-DLX5-DLX6 (7q21.3) locus contribute to genetic control of coronal nonsyndromic craniosynostosis and bone density-related traits

Paola Nicoletti,Samreen Zafer,Lital Matok,Inbar Irron,Meidva Patrick,Rotem Haklai,John Erol Evangelista,Giacomo B Marino,Avi Ma'ayan,Anshuman Sewda,Greg Holmes,Sierra R Britton,Won Jun Lee,Meng Wu,Ying Ru,Eric Arnaud,Lorenzo Botto,Lawrence C Brody,Jo C Byren,Michele Caggana,Suzan L Carmichael,Deirdre Cilliers,Kristin Conway,Karen Crawford,Araceli Cuellar,Federico Di Rocco,Michael Engel,Jeffrey Fearon,Marcia L Feldkamp,Richard Finnell,Sarah Fisher,Christian Freudlsperger,Gemma Garcia-Fructuoso,Rhinda Hagge,Yann Heuzé,Raymond J Harshbarger,Charlotte Hobbs,Meredith Howley,Mary M Jenkins,David Johnson,Cristina M Justice,Alex Kane,Denise Kay,Arun Kumar Gosain,Peter Langlois,Laurence Legal-Mallet,Angela E Lin,James L Mills,Jenny E V Morton,Peter Noons,Andrew Olshan,John Persing,Julie M Phipps,Richard Redett,Jennita Reefhuis,Elias Rizk,Thomas D Samson,Gary M Shaw,Robert Sicko,Nataliya Smith,David Staffenberg,Joan Stoler,Elizabeth Sweeney,Peter J Taub,Andrew T Timberlake,Jolanta Topczewska,Steven A Wall,Alexander F Wilson,Louise C Wilson,Simeon A Boyadjiev,Andrew O M Wilkie,Joan T Richtsmeier,Ethylin Wang Jabs,Paul A Romitti,David Karasik,Ramon Y Birnbaum,Inga Peter

DOI: https://doi.org/10.1016/j.gimo.2024.101851

Abstract:Purpose: The etiopathogenesis of coronal nonsyndromic craniosynostosis (cNCS), a congenital condition defined by premature fusion of 1 or both coronal sutures, remains largely unknown. Methods: We conducted the largest genome-wide association study of cNCS followed by replication, fine mapping, and functional validation of the most significant region using zebrafish animal model. Results: Genome-wide association study identified 6 independent genome-wide-significant risk alleles, 4 on chromosome 7q21.3 SEM1-DLX5-DLX6 locus, and their combination conferred over 7-fold increased risk of cNCS. The top variants were replicated in an independent cohort and showed pleiotropic effects on brain and facial morphology and bone mineral density. Fine mapping of 7q21.3 identified a craniofacial transcriptional enhancer (eDlx36) within the linkage region of the top variant (rs4727341; odds ratio [95% confidence interval], 0.48[0.39-0.59]; P = 1.2E-12) that was located in SEM1 intron and enriched in 4 rare risk variants. In zebrafish, the activity of the transfected human eDlx36 enhancer was observed in the frontonasal prominence and calvaria during skull development and was reduced when the 4 rare risk variants were introduced into the sequence. Conclusion: Our findings support a polygenic nature of cNCS risk and functional role of craniofacial enhancers in cNCS susceptibility with potential broader implications for bone health.
A novel cysteine-sparing NOTCH3 mutation in a Chinese family with CADASIL

Wei Ge,Hanzhe Kuang,Bin Wei,Le Bo,Zhice Xu,Xingshun Xu,Deqin Geng,Miao Sun

DOI: https://doi.org/10.1371/journal.pone.0104533

IF: 3.7

2014-08-06

PLoS ONE

Abstract:Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is an adult onset cerebral small vessel disorder caused by the mutations of the neurogenic locus notch homolog protein 3 (NOTCH3) gene. The extracellular part of NOTCH3 is composed of 34 epidermal growth factor-like (EGF-like) repeat domains. Each EGF-like domain is rich of cysteine and glycine to produce three loops that are essential for high-affinity binding to its ligand. Nearly all reported CADASIL-associated mutations result in gain or loss of a cysteine residue within the EGF-like domains. Only a few cysteine-sparing NOTCH3 mutations have been documented in the patients with CADASIL to date. Here, we reported a Chinese CADASIL family with a cysteine-sparing NOTCH3 mutation. In this family, affected patients had dizziness, memory loss, gait instability, or hemiplegia. Brain magnetic resonance imaging (MRI) showed diffuse leukoencephalopathy with confluent signal abnormalities in the periventricular white matter, basal ganglia, and centrum semiovale bilaterally. By screening the entire coding region of NOTCH3, a novel missense mutation p.G149V (c.446G>T) was found. This mutation was not detected in 400 normal controls. Considering the critical position of glycine within the C-loop of EGF-like domain and its high conservation through evolution, p.G149V mutation could be a potential pathogenic cause for CADASIL.
Pink, White, and Probability

Chaya N. Murali

DOI: https://doi.org/10.1002/ajmg.c.32119

2024-10-22

American Journal of Medical Genetics Part C Seminars in Medical Genetics

Abstract:American Journal of Medical Genetics Part C: Seminars in Medical Genetics, EarlyView.

genetics & heredity
Significance of Variants of Uncertain Significance: The Human Cost of Genetic Uncertainty

Damla Gonullu‐Rotman

DOI: https://doi.org/10.1002/ajmg.c.32109

2024-09-03

American Journal of Medical Genetics Part C Seminars in Medical Genetics

Abstract:American Journal of Medical Genetics Part C: Seminars in Medical Genetics, EarlyView.

genetics & heredity
Contribution of Common Genetic Variants to Familial Aggregation of Disease and Implications for Sequencing Studies.

Andrew Schlafly,Ruth M Pfeiffer,Eduardo Nagore,Susana Puig,Donato Calista,Paola Ghiorzo,Chiara Menin,Maria Concetta Fargnoli,Ketty Peris,Lei Song,Tongwu Zhang,Jianxin Shi,Maria Teresa Landi,Joshua Neil Sampson

DOI: https://doi.org/10.1371/journal.pgen.1008490

IF: 4.5

2019-01-01

PLoS Genetics

Abstract:Author summary Multiple members in a family can be diagnosed with the same disease. In such families, genetics may be a significant factor in disease risk. However, it remains unclear whether such familial aggregation of disease is likely due to a single highly penetrant rare variant (HPRV), many minimally penetrant common variants, or a combination of the two types of variants. We therefore use recent estimates of SNP heritability and the liability threshold model to estimate the proportion of afflicted families likely to carry a rare, causal variant. We then show that Polygenic Risk Scores (PRS) may be useful for identifying families likely to carry such a rare variant and introduce a related statistic that can be used to select families for sequencing studies trying to identify HPRV. Despite genetics being accepted as the primary cause of familial aggregation for most diseases, it is still unclear whether afflicted families are likely to share a single highly penetrant rare variant, many minimally penetrant common variants, or a combination of the two types of variants. We therefore use recent estimates of SNP heritability and the liability threshold model to estimate the proportion of afflicted families likely to carry a rare, causal variant. We then show that Polygenic Risk Scores (PRS) may be useful for identifying families likely to carry such a rare variant and therefore for prioritizing families to include in sequencing studies with that aim. Specifically, we introduce a new statistic that estimates the proportion of individuals carrying causal rare variants based on the family structure, disease pattern, and PRS of genotyped individuals. Finally, we consider data from the MelaNostrum consortium and show that, despite an estimated PRS heritability of only 0.05 for melanoma, families carrying putative causal variants had a statistically significantly lower PRS, supporting the idea that PRS prioritization may be a useful future tool. However, it will be important to evaluate whether the presence of rare mendelian variants are generally associated with the proposed test statistic or lower PRS in future and larger studies.
Diagnostic and Therapeutic Consequences

Rene Moya,Clémentine Angée,Sylvain Hanein,Fabienne Jabot-Hanin,Josseline Kaplan,Isabelle Perrault,Jean-Michel Rozet,Lucas Fares Taie

DOI: https://doi.org/10.3390/ijms25116151

IF: 5.6

2024-06-03

International Journal of Molecular Sciences

Abstract:Leber congenital amaurosis (LCA)/early-onset severe retinal dystrophy (EOSRD) stand as primary causes of incurable childhood blindness. This study investigates the clinical and molecular architecture of syndromic and non-syndromic LCA/EOSRD within a Chilean cohort (67 patients/60 families). Leveraging panel sequencing, 95.5% detection was achieved, revealing 17 genes and 126 variants (32 unique). CRB1, LCA5, and RDH12 dominated (71.9%), with CRB1 being the most prevalent (43.8%). Notably, four unique variants (LCA5 p.Glu415*, CRB1 p.Ser1049Aspfs*40 and p.Cys948Tyr, RDH12 p.Leu99Ile) constituted 62.7% of all disease alleles, indicating their importance for targeted analysis in Chilean patients. This study underscores a high degree of inbreeding in Chilean families affected by pediatric retinal blindness, resulting in a limited mutation repertoire. Furthermore, it complements and reinforces earlier reports, indicating the involvement of ADAM9 and RP1 as uncommon causes of LCA/EOSRD. These data hold significant value for patient and family counseling, pharmaceutical industry endeavors in personalized medicine, and future enrolment in gene therapy-based treatments, particularly with ongoing trials (LCA5) or advancing preclinical developments (CRB1 and RDH12).

biochemistry & molecular biology,chemistry, multidisciplinary
Genome-wide structural variant analysis identifies risk loci for non-Alzheimer's dementias

Karri Kaivola,Ruth Chia,Jinhui Ding,Memoona Rasheed,Masashi Fujita,Vilas Menon,Ronald L Walton,Ryan L Collins,Kimberley Billingsley,Harrison Brand,Michael Talkowski,Xuefang Zhao,Ramita Dewan,Ali Stark,Anindita Ray,Sultana Solaiman,Pilar Alvarez Jerez,Laksh Malik,Ted M Dawson,Liana S Rosenthal,Marilyn S Albert,Olga Pletnikova,Juan C Troncoso,Mario Masellis,Julia Keith,Sandra E Black,Luigi Ferrucci,Susan M Resnick,Toshiko Tanaka,American Genome Center,International LBD Genomics Consortium,International ALS/FTD Consortium,PROSPECT Consortium,Eric Topol,Ali Torkamani,Pentti Tienari,Tatiana M Foroud,Bernardino Ghetti,John E Landers,Mina Ryten,Huw R Morris,John A Hardy,Letizia Mazzini,Sandra D'Alfonso,Cristina Moglia,Andrea Calvo,Geidy E Serrano,Thomas G Beach,Tanis Ferman,Neill R Graff-Radford,Bradley F Boeve,Zbigniew K Wszolek,Dennis W Dickson,Adriano Chiò,David A Bennett,Philip L De Jager,Owen A Ross,Clifton L Dalgard,J Raphael Gibbs,Bryan J Traynor,Sonja W Scholz,Anthony R Soltis,Coralie Viollet,Gauthaman Sukumar,Camille Alba,Nathaniel Lott,Elisa McGrath Martinez,Meila Tuck,Jatinder Singh,Dagmar Bacikova,Xijun Zhang,Daniel N Hupalo,Adelani Adeleye,Matthew D Wilkerson,Harvey B Pollard,Ziv Gan-Or,Ekaterina Rogaeva,Alexis Brice,Suzanne Lesage,Georgia Xiromerisiou,Antonio Canosa,Adriano Chio,Giancarlo Logroscino,Gabriele Mora,Reijko Krüger,Patrick May,Daniel Alcolea,Jordi Clarimon,Juan Fortea,Isabel Gonzalez-Aramburu,Jon Infante,Carmen Lage,Alberto Lleó,Pau Pastor,Pascual Sanchez-Juan,Francesca Brett,Dag Aarsland,Safa Al-Sarraj,Johannes Attems,Steve Gentleman,Angela K Hodges,Seth Love,Ian G McKeith,Christopher M Morris,Laura Palmer,Stuart Pickering-Brown,Alan J Thomas,Claire Troakes,Matthew J Barrett,Lynn M Bekris,Kelley Faber,Margaret E Flanagan,Alison Goate,David S Goldstein,Horacio Kaufmann,Walter A Kukull,James B Leverenz,Grisel Lopez,Qinwen Mao,Eliezer Masliah,Edwin Monuki,Kathy L Newell,Jose-Alberto Palma,Matthew Perkins,Alan E Renton,Clemens R Scherzer,Vikram G Shakkottai,Ellen Sidransky,Nahid Tayebi,Randy Woltjer,Robert H Baloh,Robert Bowser,James Broach,William Camu,John Cooper-Knock,Carsten Drepper,Vivian E Drory,Travis L Dunckley,Eva Feldman,Pietro Fratta,Glenn Gerhard,Summer B Gibson,Jonathan D Glass,Matthew B Harms,Terry D Heiman-Patterson,Lilja Jansson,Janine Kirby,Justin Kwan,Hannu Laaksovirta,Francesco Landi,Isabelle Le Ber,Serge Lumbroso,Daniel Jl MacGowan,Nicholas J Maragakis,Kevin Mouzat,Liisa Myllykangas,Richard W Orrell,Lyle W Ostrow,Roger Pamphlett,Erik Pioro,Stefan M Pulst,John M Ravits,Wim Robberecht,Jeffrey D Rothstein,Michael Sendtner,Pamela J Shaw,Katie C Sidle,Zachary Simmons,Thor Stein,David J Stone,Pentti J Tienari,Miko Valori,Philip Van Damme,Vivianna M Van Deerlin,Ludo Van Den Bosch,Lorne Zinman

DOI: https://doi.org/10.1016/j.xgen.2023.100316

2023-05-04

Abstract:We characterized the role of structural variants, a largely unexplored type of genetic variation, in two non-Alzheimer's dementias, namely Lewy body dementia (LBD) and frontotemporal dementia (FTD)/amyotrophic lateral sclerosis (ALS). To do this, we applied an advanced structural variant calling pipeline (GATK-SV) to short-read whole-genome sequence data from 5,213 European-ancestry cases and 4,132 controls. We discovered, replicated, and validated a deletion in TPCN1 as a novel risk locus for LBD and detected the known structural variants at the C9orf72 and MAPT loci as associated with FTD/ALS. We also identified rare pathogenic structural variants in both LBD and FTD/ALS. Finally, we assembled a catalog of structural variants that can be mined for new insights into the pathogenesis of these understudied forms of dementia.
Phenotypic Variability in Novel Doublecortin Gene Variants Associated with Subcortical Band Heterotopia

Radha Procopio,Francesco Fortunato,Monica Gagliardi,Mariagrazia Talarico,Ilaria Sammarra,Maria Chiara Sarubbi,Donatella Malanga,Grazia Annesi,Antonio Gambardella

DOI: https://doi.org/10.3390/ijms25105505

2024-05-18

Abstract:Doublecortin, encoded by the DCX gene, plays a crucial role in the neuronal migration process during brain development. Pathogenic variants of the DCX gene are the major causes of the "lissencephaly (LIS) spectrum", which comprehends a milder phenotype like Subcortical Band Heterotopia (SBH) in heterozygous female subjects. We performed targeted sequencing in three unrelated female cases with SBH. We identified three DCX-related variants: a novel missense (c.601A>G: p.Lys201Glu), a novel nonsense (c.210C>G: p.Tyr70*), and a previously identified nonsense (c.907C>T: p.Arg303*) variant. The novel c.601A>G: p.Lys201Glu variant shows a mother-daughter transmission pattern across four generations. The proband exhibits focal epilepsy and achieved seizure freedom with a combination of oxcarbazepine and levetiracetam. All other affected members have no history of epileptic seizures. Brain MRIs of the affected members shows predominant fronto-central SBH with mixed pachygyria on the overlying cortex. The two nonsense variants were identified in two unrelated probands with SBH, severe drug-resistant epilepsy and intellectual disability. These novel DCX variants further expand the genotypic-phenotypic correlations of lissencephaly spectrum disorders. Our documented phenotypic descriptions of three unrelated families provide valuable insights and stimulate further discussions on DCX-SBH cases.
Functional biology of the Steel syndrome founder allele and evidence for clan genomics derivation of COL27A1 pathogenic alleles worldwide

Claudia Gonzaga-Jauregui,Gozde Yesil,Harikiran Nistala,Alper Gezdirici,Yavuz Bayram,Kalyan C. Nannuru,Davut Pehlivan,Bo Yuan,Johanna Jimenez,Yavuz Sahin,Ingrid S. Paine,Zeynep Coban Akdemir,Saathyaki Rajamani,Jeffrey Staples,John Dronzek,Kristen Howell,Jawid M. Fatih,Silvia Smaldone,Alan E. Schlesinger,Norman Ramírez,Alberto S. Cornier,Melissa A. Kelly,Robert Haber,Shek Man Chim,Kristy Nieman,Nan Wu,Johnathon Walls,William Poueymirou,Chia-Jen Siao,V. Reid Sutton,Marc S. Williams,Jennifer E. Posey,Richard A. Gibbs,Simon Carlo,David H. Tegay,Aris N. Economides,James R. Lupski,

DOI: https://doi.org/10.1038/s41431-020-0632-x

2020-05-06

European Journal of Human Genetics

Abstract:Abstract Previously we reported the identification of a homozygous COL27A1 (c.2089G>C; p.Gly697Arg) missense variant and proposed it as a founder allele in Puerto Rico segregating with Steel syndrome (STLS, MIM #615155); a rare osteochondrodysplasia characterized by short stature, congenital bilateral hip dysplasia, carpal coalitions, and scoliosis. We now report segregation of this variant in five probands from the initial clinical report defining the syndrome and an additional family of Puerto Rican descent with multiple affected adult individuals. We modeled the orthologous variant in murine Col27a1 and found it recapitulates some of the major Steel syndrome associated skeletal features including reduced body length, scoliosis, and a more rounded skull shape. Characterization of the in vivo murine model shows abnormal collagen deposition in the extracellular matrix and disorganization of the proliferative zone of the growth plate. We report additional COL27A1 pathogenic variant alleles identified in unrelated consanguineous Turkish kindreds suggesting Clan Genomics and identity-by-descent homozygosity contributing to disease in this population. The hypothesis that carrier states for this autosomal recessive osteochondrodysplasia may contribute to common complex traits is further explored in a large clinical population cohort. Our findings augment our understanding of COL27A1 biology and its role in skeletal development; and expand the functional allelic architecture in this gene underlying both rare and common disease phenotypes.

genetics & heredity,biochemistry & molecular biology
Two novel variants in CEP152 caused Seckel syndrome 5 in a Chinese family

Li Zhang,Yanling Teng,Haoran Hu,Huimin Zhu,Juan Wen,Desheng Liang,Zhuo Li,Lingqian Wu

DOI: https://doi.org/10.3389/fgene.2022.1052915

IF: 3.7

2023-01-05

Frontiers in Genetics

Abstract:Background: Seckel syndrome (SCKL) is a rare autosomal recessive inherited disorder, which is mainly characterized by intrauterine and postnatal growth restrictions, microcephaly, intellectual disability, and a typical "bird-head" facial appearance. Here, we aimed to identify the genetic etiology of a family with suspected SCKL. Methods: This study enrolled a Chinese family suspected of SCKL with their detailed family history and clinical data. We performed karyotype analysis, copy number variation sequencing (CNV-seq), and trio whole-exome sequencing (WES) to explore the genetic etiology in the proband. Furthermore, the quantitative real-time polymerase chain reaction (PCR) and reverse transcription-PCR (RT-PCR) were conducted to confirm the pathogenicity of novel variants. Results: The karyotype analysis and CNV-seq were normal in the proband. Two novel variants in CEP152 , c.1060C>T (p.Arg354*) and c.1414-14A>G, were identified in the proband through trio-WES. The qPCR results showed that the total CEP152 mRNA expression levels were significantly reduced in c.1060C>T (p.Arg354*) and c.1414-14A>G compared with healthy control individuals. Moreover, aberrant skipping of exon 12 due to the non-canonical splice-site variant was revealed by RT-PCR and Sanger sequencing. Conclusion: Our findings expanded pathogenic variant spectra in SCKL and offered new insights into the pathogenicity of a non-classical splice-site variant in CEP152 , which provided additional information for helping the family improve pregnancy plans in the future.

genetics & heredity
Loss of heterozygosity in CCM2 cDNA revealing a structural variant causing multiple cerebral cavernous malformations

Annabelle Chaussenot,Xavier Ayrignac,Nicolas Chatron,Terry Granchon-Riolzir,Pierre Labauge,Elisabeth Tournier-Lasserve,Florence Riant

DOI: https://doi.org/10.1038/s41431-024-01626-7

2024-05-17

European Journal of Human Genetics

Abstract:Loss-of-function variants in CCM1/KRIT1 , CCM2/MGC4607 , and CCM3/PDCD10 genes are identified in the vast majority of familial cases with multiple cerebral cavernous malformations. However, genomic DNA sequencing combined with large rearrangement screening fails to detect a pathogenic variant in 5% of the patients. We report a family with two affected members harboring multiple CCM lesions, one with severe hemorrhages and one asymptomatic. No causative variant was detected using DNA sequencing of the three CCM genes, CNV detection analysis, and RNA sequencing. However, a loss of heterozygosity in CCM2 was observed on cDNA sequences in one of the two affected members, which strongly suggested that this locus might be involved. Whole genome sequencing (WGS) identified a balanced structural variant on chromosome 7 with a breakpoint interrupting the CCM2 gene, preventing normal mRNA synthesis. These data underline the importance of WGS in undiagnosed patients with typical multiple CCM.

genetics & heredity,biochemistry & molecular biology
De Novo Pathogenic Variants in CACNA1E Cause Developmental and Epileptic Encephalopathy with Contractures, Macrocephaly, and Dyskinesias (vol 103, Pg 666, 2018)

Katherine L. Helbig,Robert J. Lauerer,Jacqueline C Bahr,Ivana A. Souza,Candace T. Myers,Betül Börkü Uysal,Niklas Schwarz,María A. Gandini,Sun Huang,Boris Keren,Cyril Mignot,Alexandra Afenjar,Thierry Billette de Villemeur,Delphine Héron,Caroline Nava,Stéphanie Valence,Julien Buratti,Christina Fagerberg,Kristina P. Soerensen,Maria Kibæk,Erik‐Jan Kamsteeg,David A. Koolen,Boudewijn Gunning,Helenius J. Schelhaas,Michael C. Kruer,Jordana Fox,Somayeh Bakhtiari,Randa Jarrar,Sergio Padilla-López,Kristin Lindstrom,Sheng Jin,Xue Zeng,Kaya Bilgüvar,Antigone Papavasileiou,Qinghe Xing,Changlian Zhu,Katja Boysen,Filippo Pinto e Vairo,Brendan C. Lanpher,Eric W. Klee,Jan‐Mendelt Tillema,Eric T. Payne,Margot A. Cousin,Teresa Kruisselbrink,Myra J. Wick,Joshua Baker,Eric Haan,Nicholas J. Smith,Azita Sadeghpour,Erica E. Davis,Nicholas Katsanis,Mark Corbett,Alastair H. MacLennan,Jozef Gécz,Saskia Biskup,Eva Goldmann,Lance H. Rodan,Elizabeth Kichula,Eric Segal,Kelly E. Jackson,Alexander Asamoah,David Dimmock,Julie McCarrier,Lorenzo D. Botto,Francis Filloux,Tatiana Tvrdik,Gregory D. Cascino,Sherry Klingerman,Catherine M. Neumann,Raymond Wang,Jessie C. Jacobsen,Melinda Nolan,Russell G. Snell,Klaus Lehnert,Lynette G. Sadleir,Britt‐Marie Anderlid,Malin Kvarnung,Renzo Guerrini,Michael J. Friez,Michael J. Lyons,Jennifer Leonhard,Gabriel Kringlen,Kari Casas,Christelle Moufawad El Achkar,Lacey Smith,Alexander Rotenberg,Annapurna Poduri,Alba Sanchis-Juan,Keren Carss,Julia Rankin,Adam Zeman,F. Lucy Raymond,Moira Blyth,Bronwyn Kerr,Karla Ruiz,Jill E. Urquhart,Imelda Hughes,Siddharth Banka,Ulrike B. S. Hedrich,Ingrid E. Scheffer,Ingo Helbig,Gerald W. Zamponi,Holger Lerche,Heather C. Mefford

2019-01-01

Abstract:(The American Journal of Human Genetics 103, 666–678; November 1, 2018) In the version of this article originally published online, Qinghe Xing's name was misspelled as Qinghe Xin. Also, Azita Sadeghpour, Erica E. Davis, and Nicholas Katsanis (all at Center for Human Disease Modeling, Duke University Medical Center, Durham, NC 27701, USA) and the Task Force for Neonatal Genomics were omitted from the author list. The members of the Task Force for Neonatal Genomics are as follows: Alexander Allori, Misha Angrist, Patricia Ashley, Margarita Bidegain, Brita Boyd, Eileen Chambers, Heidi Cope, C. Michael Cotten, Theresa Curington, Erica E. Davis, Sarah Ellestad, Kimberley Fisher, Amanda French, William Gallentine, Ronald Goldberg, Kevin Hill, Sujay Kansagra, Nicholas Katsanis, Sara Katsanis, Joanne Kurtzberg, Jeffrey Marcus, Marie McDonald, Mohammed Mikati, Stephen Miller, Amy Murtha, Yezmin Perilla, Carolyn Pizoli, Todd Purves, Sherry Ross, Azita Sadeghpour, Edward Smith, and John Wiener. The authors apologize for these omissions.
Rare variant contribution to the heritability of coronary artery disease

Ghislain Rocheleau,Shoa L Clarke,Gaëlle Auguste,Natalie R Hasbani,Alanna C Morrison,Adam S Heath,Lawrence F Bielak,Kruthika R Iyer,Erica P Young,Nathan O Stitziel,Goo Jun,Cecelia Laurie,Jai G Broome,Alyna T Khan,Donna K Arnett,Lewis C Becker,Joshua C Bis,Eric Boerwinkle,Donald W Bowden,April P Carson,Patrick T Ellinor,Myriam Fornage,Nora Franceschini,Barry I Freedman,Nancy L Heard-Costa,Lifang Hou,Yii-Der Ida Chen,Eimear E Kenny,Charles Kooperberg,Brian G Kral,Ruth J F Loos,Sharon M Lutz,JoAnn E Manson,Lisa W Martin,Braxton D Mitchell,Rami Nassir,Nicholette D Palmer,Wendy S Post,Michael H Preuss,Bruce M Psaty,Laura M Raffield,Elizabeth A Regan,Stephen S Rich,Jennifer A Smith,Kent D Taylor,Lisa R Yanek,Kendra A Young,NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium,Austin T Hilliard,Catherine Tcheandjieu,Patricia A Peyser,Ramachandran S Vasan,Jerome I Rotter,Clint L Miller,Themistocles L Assimes,Paul S de Vries,Ron Do,Pramod Anugu,Paul Auer,Lucas Barwick,Diane Becker,Cara Carty,Peter Castaldi,Mark Chaffin,Yi-Cheng Chang,Seung Hoan Choi,Ren-Hua Chung,Carolyn Crandall,Sean David,Lisa de Las Fuentes,Ranjan Deka,Dawn DeMeo,Qing Duan,Charles Eaton,Lynette Ekunwe,Adel El Boueiz,Shanshan Gao,Yan Gao,Margery Gass,Auyon Ghosh,Daniel Grine,Michael Hall,Craig Hersh,Brian Hobbs,Chao Agnes Hsiung,Yi-Jen Hung,Haley Huston,Chii Min Hwu,Rebecca Jackson,Jill Johnsen,Christoph Lange,Ethan Lange,Meryl LeBoff,Wen-Jane Lee,Yun Li,Simin Liu,Yu Liu,Susan Mathai,Hao Mei,Rakhi Naik,Take Naseri,Bonnie Neltner,Heather Ochs-Balcom,David T Paik,Cora Parker,Marco Perez,Ulrike Peters,Lawrence S Phillips,Julia Powers Becker,Muagututi'a Sefulva Reupena,Carolina Roselli,Pamela Russell,Ester Cerdeira Sabino,Kevin Sandow,Karen Schwander,Frank Sciurba,Brian Silver,Sylvia Smoller,Beverly Snively,Garrett Storm,Yun Ju Sung,Hua Tang,Margaret Taub,Lesley Tinker,David Tirschwell,Hemant Tiwari,Dhananjay Vaidya,Tarik Walker,Robert Wallace,Avram Walts,Lu-Chen Weng,Ivana Yang,Snow Xueyan Zhao

DOI: https://doi.org/10.1038/s41467-024-52939-6

2024-10-09

Abstract:Whole genome sequences (WGS) enable discovery of rare variants which may contribute to missing heritability of coronary artery disease (CAD). To measure their contribution, we apply the GREML-LDMS-I approach to WGS of 4949 cases and 17,494 controls of European ancestry from the NHLBI TOPMed program. We estimate CAD heritability at 34.3% assuming a prevalence of 8.2%. Ultra-rare (minor allele frequency ≤ 0.1%) variants with low linkage disequilibrium (LD) score contribute ~50% of the heritability. We also investigate CAD heritability enrichment using a diverse set of functional annotations: i) constraint; ii) predicted protein-altering impact; iii) cis-regulatory elements from a cell-specific chromatin atlas of the human coronary; and iv) annotation principal components representing a wide range of functional processes. We observe marked enrichment of CAD heritability for most functional annotations. These results reveal the predominant role of ultra-rare variants in low LD on the heritability of CAD. Moreover, they highlight several functional processes including cell type-specific regulatory mechanisms as key drivers of CAD genetic risk.
Editorial on the Special Issue "Genetic and Molecular Basis of Inherited Disorders"

Rodolfo Iuliano,Francesco Paduano

DOI: https://doi.org/10.3390/genes15101259

IF: 4.141

2024-09-28

Genes

Abstract:This Special Issue of Genes, titled "Genetic and Molecular Basis of Inherited Disorders", presents a collection of pioneering research articles that advance our understanding of the genetic mechanisms underlying various hereditary diseases. The studies employ cutting-edge genomic techniques, including next-generation sequencing and genome-wide association studies, to elucidate novel genetic variants and their functional implications. Key investigations span a diverse range of conditions, from congenital idiopathic nystagmus and hereditary hearing loss to familial hypercholesterolemia and rare cancer predisposition syndromes. Notable findings include the identification of new gene–disease associations in congenital anomalies of the kidney and urinary tract, the discovery of large genomic rearrangements in breast cancer susceptibility, and insights into the genetic basis of pigmentary traits and associated disease risks. This Special Issue also highlights the significance of copy number variations and rare structural variants in disease pathogenesis. Collectively, these studies underscore the complexity of genetic variation in inherited disorders and demonstrate the critical role of integrating advanced genetic analyses with clinical practice to enhance diagnostic precision and develop targeted therapeutic approaches.

genetics & heredity
Evaluation of the genetic basis of familial-associated early-onset hematologic cancers in an ancestral/ethnically diverse population

Qianxi Feng,Keren Xu,Mancy Shah,Shaobo Li,Andrew D. Leavitt,Lucy A. Godley,Adam J. De Smith,Joseph L. Wiemels

DOI: https://doi.org/10.3324/haematol.2023.284224

2024-01-12

Haematologica

Abstract:Genetic predisposition to hematologic malignancies has historically been addressed utilizing patients recruited from clinical trials and pedigrees constructed at major treatment centers. Such efforts leave unexplored the genetic basis of variations in risk by race/ethnic group shown in population-based surveillance data where cancer registration, compulsory by law, delivers universal enrollment. To address this, we performed exome sequencing on DNA isolated from newborn bloodspots derived from sibling pairs with early-onset cancers across California in which at least one of the siblings developed a hematologic cancer, using unbiased recruitment from the full state population. We identified pathogenic/likely pathogenic (P/LP) variants among 1172 selected cancer genes that were private or present at low allele frequencies in reference populations. Within 64 subjects from 32 families, we found 9 LP variants shared between siblings, and an additional 7 such variants in singleton children (not shared with their sibling). In eight of the shared cases, the ancestral origin of the local haplotype that carries P/LP variants matched the dominant global ancestry of study participant families. This was the case for Latino sibling pairs on FLG and CBLB, non-Latino White sibling pairs in TP53 and NOD2, and a shared GATA2 variant for a non-Latino Black sibling pair. A new inherited mutation in HABP2 was identified in a sibling pair, one with diffuse large B-cell lymphoma and the other with neuroblastoma. Overall, the profile of P/LP germline variants across ancestral/ethnic groups suggests that rare alleles contributing to hematologic diseases originate within their race/ethnic origin parental populations, demonstrating the value of this discovery process in diverse, population-based registries.

hematology
Actionable Variants of Unknown Significance in Inherited Arrhythmogenic Syndromes: A Further Step Forward in Genetic Diagnosis

Estefanía Martínez-Barrios,Andrea Greco,José Cruzalegui,Sergi Cesar,Nuria Díez-Escuté,Patricia Cerralbo,Fredy Chipa,Irene Zschaeck,Miguel Fogaça-da-Mata,Carles Díez-López,Elena Arbelo,Simone Grassi,Antonio Oliva,Rocío Toro,Georgia Sarquella-Brugada,Oscar Campuzano

DOI: https://doi.org/10.3390/biomedicines12112553

IF: 4.757

2024-11-09

Biomedicines

Abstract:Background/Objectives: Inherited arrhythmogenic syndromes comprise a heterogenic group of genetic entities that lead to malignant arrhythmias and sudden cardiac death. Genetic testing has become crucial to understand the disease etiology and allow for the early identification of relatives at risk; however, it requires an accurate interpretation of the data to achieve a clinically actionable outcome. This is particularly challenging for the large number of rare variants obtained by current high-throughput techniques, which are mostly classified as of unknown significance. Methods: In this work, we present a new algorithm for the genetic interpretation of the remaining rare variants in order to shed light on their potential clinical implications and reduce the burden of unknown significance. Results: Our study illustrates the potential utility of our individualized comprehensive stepwise analyses focused on the rare variants associated with IAS, which are currently classified as ambiguous, to further determine their trends towards pathogenicity or benign traits. Conclusions: We advocate for personalized disease-focused population frequency data and family segregation analyses for all rare variants that remain ambiguous to further clarify their role. The current ambiguity should not influence medical decisions, but a potential deleterious role would suggest a closer clinical follow-up and frequent genetic data review for a more personalized clinical approach.

biochemistry & molecular biology,medicine, research & experimental,pharmacology & pharmacy
Case Report: Novel Biallelic Variants in DNAJC21 Causing an Inherited Bone Marrow Failure Spectrum Phenotype: An Odyssey to Diagnosis

Adela Chirita-Emandi,Carmen-Angela-Maria Petrescu,Cristian G Zimbru,Florina Stoica,Catalin Marian,Andreea Ciubotaru,Mihaela Bataneant,Maria Puiu

DOI: https://doi.org/10.3389/fgene.2022.870233

2022-04-08

Abstract:Bone marrow failure represents an umbrella diagnosis for several life-threatening disorders. In many people, the etiology remains unknown for a long time, leading to an odyssey to diagnosis, with numerous tests performed and sometimes inappropriate treatment. Biallelic pathogenic variants in the DNAJC21 gene were recently discovered to cause bone marrow failure syndrome type 3, having phenotypic overlap with Fanconi anemia, dyskeratosis congenita, Shwachman-Diamond syndrome, and Diamond-Blackfan anemia. Herein, we report an 8-year-old boy, with normal intellect, presenting bone marrow failure; growth retardation; failure to thrive; recurrent infections (including sepsis); cryptorchidia; skeletal, skin, teeth, and hair abnormalities; joint hypermobility; eczema; palpebral ptosis; high myopia; rod-cone retinal dystrophy; and short telomeres. He underwent several tests and evaluations, including genetic investigations (panel and exome sequencing), before the DNAJC21 gene was known to cause disease. Whole-genome sequencing performed at the age of 7 years, identified two novel, pathogenic, and compound heterozygous variants in the DNAJC21 gene: NM_001012339.3:c.148C>T (stopgain-maternal origin), p.Gln50∗ and c.643_644delinsTTT (frameshift paternal origin), and p.Lys215Phefs∗71. He received aggressive treatments for his multisystem disease: blood cell transfusions, high-dose corticosteroids, immunoglobulins, multiple antibiotics, vitamins, growth hormone, and others. However, allogeneic hematopoietic stem cell transplantation was avoided. The clinical evolution of bone marrow failure and recurrent infections stabilized with age, yet the myopia progressed. Exocrine pancreatic insufficiency was not detected. This report widens the molecular and clinical understanding of bone marrow failure syndrome type 3. Genome sequencing directed a precise diagnosis that improved patient management and enabled family genetic counseling.
Invisible strings

Ariel Ellen Shaver Lee

DOI: https://doi.org/10.1002/ajmg.c.32107

2024-08-19

American Journal of Medical Genetics Part C Seminars in Medical Genetics

Abstract:American Journal of Medical Genetics Part C: Seminars in Medical Genetics, EarlyView.

genetics & heredity

Family Lore, a Variant of Uncertain Significance, and CADASIL

Novel KRIT1/CCM1 and MGC4607/CCM2 Gene Variants in Chinese Families with Cerebral Cavernous Malformations

De novo variants implicate chromatin modification, transcriptional regulation, and retinoic acid signaling in syndromic craniosynostosis

Regulatory elements in SEM1-DLX5-DLX6 (7q21.3) locus contribute to genetic control of coronal nonsyndromic craniosynostosis and bone density-related traits

A novel cysteine-sparing NOTCH3 mutation in a Chinese family with CADASIL

Pink, White, and Probability

Significance of Variants of Uncertain Significance: The Human Cost of Genetic Uncertainty

Contribution of Common Genetic Variants to Familial Aggregation of Disease and Implications for Sequencing Studies.

Diagnostic and Therapeutic Consequences

Genome-wide structural variant analysis identifies risk loci for non-Alzheimer's dementias

Phenotypic Variability in Novel Doublecortin Gene Variants Associated with Subcortical Band Heterotopia

Functional biology of the Steel syndrome founder allele and evidence for clan genomics derivation of COL27A1 pathogenic alleles worldwide

Two novel variants in CEP152 caused Seckel syndrome 5 in a Chinese family

Loss of heterozygosity in CCM2 cDNA revealing a structural variant causing multiple cerebral cavernous malformations

De Novo Pathogenic Variants in CACNA1E Cause Developmental and Epileptic Encephalopathy with Contractures, Macrocephaly, and Dyskinesias (vol 103, Pg 666, 2018)

Rare variant contribution to the heritability of coronary artery disease

Editorial on the Special Issue "Genetic and Molecular Basis of Inherited Disorders"

Evaluation of the genetic basis of familial-associated early-onset hematologic cancers in an ancestral/ethnically diverse population

Actionable Variants of Unknown Significance in Inherited Arrhythmogenic Syndromes: A Further Step Forward in Genetic Diagnosis

Case Report: Novel Biallelic Variants in DNAJC21 Causing an Inherited Bone Marrow Failure Spectrum Phenotype: An Odyssey to Diagnosis

Invisible strings